EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/569879
...IS ALSO FULLY REIMBURSABLE. ® INDICATIONS AND USAGE OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain. References: 1. OMIDRIA [package insert]. Seattle, WA: Omeros Corporation; 2015. 2. Omeros data on fi le. 3. Department of Health and Human Services. Centers for Medicare and Medicaid Services. MLN Matters. Number MM9014. 2014:1-19. 4. Federal Register, April 7, 2000, 65 FR. 5. Kaiser Family Foundation analysis of the CMS Medicare Current Benefi ciary Survey Cost and Use File, 2010. 6. Lindstrom RL, et al. Clin Ophthalmol. 2014;8:1735-1744. 7. Katsev D, Katsev C, Pinnow J. Intracameral ketorolac concentration after topical ketorolac administration prior to cataract surgery. Electronic poster session presented at: American Society of Cataract and Refractive Surgery. 2015 ASCRS-ASOA Symposium and Congress; 2015 Apr 17-21; San Diego, CA. Study sponsored by Omeros Corporation. 8. Florio V, Cowan L, Prusakiewicz JJ, Bentley E, Waterbury LD. Ocular tissue distribution of ketorolac after administration of OMS302 to dogs during IOL replacement. Electronic poster session presented at: American Society of Cataract and Refractive Surgery. 2015 ASCRS-ASOA Symposium and Congress; 2015 April 17-21; San Diego, CA. 9. Waterbury LD, et al. Curr Med Res Opin. 2006;22:1133-1140. 10. Hovanesian JA, et al. J Cataract Refract Surg. 2015 [in press]. FULLY REIMBURSABLE ACROSS ALL PAYER TYPES 2,4,5 REIMBURSED SEPARATELY FROM THE BUNDLED PAYMENT UNTIL DECEMBER 31, 2017 3,4 AFTER BUNDLING, POSITIVE EFFECT ON FACILITY FEES 4 NO EFFECT ON PHYSICIAN FEES; PASSTHROUGH PAYMENTS HAVE NO EFFECT ON HEALTHCARE SYSTEM 4 Reimbursement information is based on Omeros data on fi le. Omeros does not guarantee reimbursement for any particular patient. Contact 1-844-OMEROS1 (1-844-663-7671) for more information about how to submit for OMIDRIA reimbursement.

